60 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Brooklyn ImmunoTherapeutics, Inc. BTX shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of license for mRNA technology platform to develop genetically edited cells for multiple cancers and blood disorders.
  • Uxin Limited UXIN shares jumped 45.3% to close at $2.95 on Wednesday after the company reported Q3 earnings results.
  • Regional Health Properties, Inc. RHE surged 44.8% to settle at $6.37.
  • Galectin Therapeutics Inc. GALT rose 22.6% to close at $5.10. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
  • Aurora Mobile Limited JG shares gained 19.6% to close at $4.21 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.
  • Shineco, Inc. TYHT surged 17.7% to close at $9.79.
  • ClearSign Technologies Corporation CLIR surged 16.3% to close at $5.00 as the company received certification for firetube boiler burner in China.
  • Vyant Bio, Inc. VYNT jumped 16% to close at $4.65. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
  • Enveric Biosciences, Inc. ENVB surged 15.4% to close at $2.70.
  • China Green Agriculture, Inc. CGA gained 15.4% to settle at $13.68.
  • Unitil Corporation UTL climbed 15.3% to settle at $57.57. Unitil will replace Waddell & Reed Financial in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
  • Genworth Financial, Inc. GNW rose 15.2% to close at $4.40. Genworth Financial will replace Glu Mobile in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
  • VistaGen Therapeutics, Inc. VTGN gained 15.1% to close at $2.44.
  • 22nd Century Group, Inc. XXII shares rose 14.5% to settle at $5.62.
  • Century Casinos, Inc. CNTY surged 14.2% to close at $12.81 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a price target of $18 per share.
  • Ault Global Holdings, Inc. DPW jumped 14% to settle at $2.85.
  • Boxlight Corporation BOXL shares gained 13.9% to settle at $2.78. Maxim Group reiterated Boxlight with a Buy and announced a $6 price target.
  • Mind Medicine (MindMed) Inc. MNMD climbed 13.7% to close at $4.57. Mind Medicine commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday.
  • Pitney Bowes Inc. PBI gained 13.7% to settle at $9.73.
  • Haverty Furniture Companies, Inc. HVT surged 13.5% to close at $46.52 after the company reported better-than-expected Q1 results.
  • U.S. Silica Holdings, Inc. SLCA gained 13.3% to settle at $13.08.
  • Everi Holdings Inc. EVRI surged 12.6% to close at $17.95 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a price target of $25 per share.
  • Manhattan Associates, Inc. MANH jumped 12.2% to close at $144.02 following upbeat quarterly results.
  • CyberOptics Corporation CYBE surged 11.7% to close at $33.51 after the company reported better-than-expected Q1 results. The company also announced it received a new order valued at approximately $2.4 million for its mini LED inspection and metrology.
  • Shopify Inc. SHOP gained 11.4% to close at $1,288.80 after the company reported better-than-expected Q1 results.
  • Deutsche Bank Aktiengesellschaft DB climbed 11.1% to close at $13.72 after reporting upbeat quarterly profit.
  • GSX Techedu Inc. GSX jumped 11% to settle at $35.51. The company recently reported FY20 earnings results.
  • Smart Share Global Limited EM gained 8.7% to close at $9.21.
  • NCR Corporation NCR gained 8.7% to close at $45.96 after the company reported better-than-expected Q1 results.
  • Creatd, Inc. CRTD rose 8% to settle at $4.03 after the company reported strategic investment in Untamed Photographer, NFT Collaboration, and Vocal Community and Challenge Sponsorships.
  • RiceBran Technologies RIBT gained 7.6% to close at $1.27 after jumping around 27% on Tuesday.
  • Genpact Limited G rose 5.9% to close at $47.67. Genpact will replace Genworth Financial in the S&P MidCap 400 prior to the opening of trading on Monday, May 3.
  • Calliditas Therapeutics AB CALT rose 4.3% to close at $30.00 after the company said the FDA has accepted the submission and granted priority review for the new drug application for Nefecon, a down regulator of IgA1 for the treatment of IgA nephropathy. The FDA has set a PDUFA goal date of Sept. 15.
  • Alphabet Inc. GOOGL rose 3% to close at $2,359.04 after the company reported better-than-expected results for its first quarter and also announced a $50 billion Class C capital stock buyback program.

 

Check out these big penny stock gainers and losers

Losers

  • Urban Tea, Inc. MYT fell 37.5% to close at $2.90 after the company reported pricing of approximately $25million registered direct offering.
  • Protalix BioTherapeutics, Inc. PLX shares tumbled 32.6% to close at $3.93 on Wednesday. Protalix BioTherapeutics and partner Chiesi announced that they received a complete response letter from the FDA regarding the biologics license application, seeking accelerated approval of pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease.
  • R. R. Donnelley & Sons Company RRD dipped 22.3% to close at $4.59 after the company reported worse-than-expected Q1 earnings.
  • Revolution Medicines, Inc. RVMD fell 20.8% to close at $33.80.
  • Atea Pharmaceuticals, Inc. AVIR fell 20.7% to settle at $26.65.
  • Benitec Biopharma Inc. BNTC fell 20.6% to settle at $4.35 after the company reported that, due to demand, the underwriter has agreed to increase the size of the previously announced offering of 3.036 million shares of common stock at a price of $4.25 per share, for raising gross proceeds of $12.9 million.
  • Nymox Pharmaceutical Corporation NYMX fell 15% to close at $2.09. Nymox Pharmaceutical’s director recently purchased 40,000 shares at an average price of $2.08 per share.
  • Pinterest, Inc. PINS fell 14.5% to close at $66.33 after the company reported Q1 earnings results.
  • Enphase Energy, Inc. ENPH fell 14.1% to close at $146.91 after the company issued weak Q2 sales guidance.
  • Veoneer, Inc. VNE dipped 13.7% to close at $22.99 following downbeat quarterly sales.
  • REV Group, Inc. REVG fell 12.6% to settle at $18.38.
  • Reviva Pharmaceuticals Holdings, Inc. RVPH dipped 12.5% to close at $6.39. Reviva Pharmaceuticals recently announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia.
  • Spotify Technology S.A. SPOT dropped 12.3% to close at $256.84 after the company reported Q1 earnings results.
  • BioVie Inc. BIVI fell 12.2% to close at $18.88 after the company announced it acquired biopharma assets from privately held NeurMedix.
  • Medley Management Inc. MDLY shares dropped 12% to settle at $5.36.
  • Mammoth Energy Services, Inc. TUSK fell 10.6% to close at $3.79.
  • F5 Networks, Inc. FFIV fell 9.1% to settle at $186.70 after the company reported Q2 results and issued Q3 forecast.
  • Nxt-ID, Inc. NXTD fell 8.5% to close at $0.9426 after climbing around 15% on Tuesday.
  • Agrify Corporation AGFY dropped 8.4% to settle at $11.26.
  • AzurRx BioPharma, Inc. AZRX fell 8.3% to close at $0.9446 after jumping over 15% on Tuesday.
  • Helen of Troy Limited HELE dropped 7.9% to settle at $206.08 following Q4 results.
  • NetSol Technologies, Inc. NTWK fell 7.6% to settle at $4.99 potentially on profit-taking after the stock rallied roughly 35% yesterday.
  • Amgen Inc. AMGN fell 7.2% to settle at $236.71 after the company reported worse-than-expected Q1 results.
  • Aldeyra Therapeutics, Inc. ALDX fell 6.2% to close at $13.93 after the company reported a proposed $125 million public offering of common stock.
  • Steven Madden, Ltd. SHOO fell 5.8% to close at $40.02 after the company issued Q2 guidance below analyst estimates.
  • Microsoft Corporation MSFT shares fell 2.8% to close at $254.56 after the company reported Q3 earnings results.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasApplication SoftwareInformation TechnologyMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...